TABLE 3.
Number and percentage of episodes of positive cultures for carbapenem-resistant* Enterobacteriaceae† (N = 72) from three communities,§ by selected characteristics — United States, Emerging Infections Program, August–December 2011
| Characteristic | No. | (%) |
|---|---|---|
| Patient characteristics | ||
| Female sex | 36 | (50) |
| White race | 32 | (45) |
| Median age (range) (yrs) | 60 | (8–91) |
| <18 | 2 | (3) |
| ≥65 | 30 | (42) |
| Type of health-care exposure ¶ | ||
| Hospitalization | 34 | (72) |
| Presence of urinary catheter within the past 2 days | 22 | (47) |
| Long-term care facility | 17 | (36) |
| Surgery | 12 | (26) |
| Presence of other indwelling device within the past 2 days | 11 | (23) |
| Presence of central line within the past 2 days | 9 | (19) |
| None | 6 | (4) |
| Dialysis | 3 | (13) |
| Outcome | ||
| Hospitalized | 59 | (82) |
| Intensive-care unit within 7 days of positive culture | 16 | (22) |
| Died | 3 | (4) |
*
Nonsusceptible to imipenem, meropenem, or doripenem and resistant to all third-generation cephalosporins tested (e.g., ceftriaxone, cefotaxime, ceftazidime).
†
Klebsiella pneumoniae, Klebsiella oxytoca, Escherichia coli, Enterobacter aerogenes, or Enterobacter cloacae.
§
Atlanta, Georgia; Minneapolis-St. Paul, Minnesota; and Portland, Oregon.
¶
Within the past year, unless noted otherwise, among community-onset cultures (n=47).